Molecular target
Mast Cell Stabilization Pathway
Mast cells release histamine and other inflammatory mediators on activation. Stabilization (preventing degranulation) is the mechanism of cromolyn-type drugs and several plants such as quercetin, butterbur, and stinging nettle.
Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.
No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.
Pharmaceutical agents
Drugs that act on Mast Cell Stabilization Pathway
These medications have Mast Cell Stabilization Pathway among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.
Botanical connections
Plants whose compounds act on Mast Cell Stabilization Pathway
Each plant below contains a named compound documented to act on Mast Cell Stabilization Pathway. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.
- ParthenolideSesquiterpene lactone
Primary anti-migraine compound; inhibits platelet serotonin release, mast cell degranulation, and 5-LOX-mediated leukotriene synthesis. Standardization to parthenolide content is the basis of clinically tested products.
- Flavonoids (diosmin, hesperidin, limonicitrin)Flavonoids
In vitro studies report histamine release inhibition from mast cells; broader anti-inflammatory activity investigated via NF-κB modulation. Clinical relevance requires further confirmation.
- Quercetinflavonoid
Inhibits platelet aggregation via TXA2 pathway, mild ACE inhibition, and stabilizes mast cells (reducing histamine release).
- QuercetinFlavonol
Beyond mast-cell stabilization and H1 antagonism, quercetin is a broadly characterized protein/receptor tyrosine-kinase modulator (including JAK/STAT) investigated in preclinical models. Research only — not a treatment claim.
- Quercetin + carotenoidsflavonoid + pigment
Anti-inflammatory and mast-cell-stabilizing effects in nettle leaf — the basis for anti-allergic and adjunctive musculoskeletal effects.
- KhellinFurochromone
Khellin has been reported to inhibit L-type voltage-gated calcium channels, producing smooth-muscle relaxation in bronchial and vascular tissues; it is also reported to stabilise mast cells, reducing mediator release. These mechanisms are considered the pharmacological basis for khellin's structural inspiration for the development of cromolyn sodium and nifedipine, per review literature.